Literature DB >> 943254

Plasma renin activity (PRA) and aldosterone (PA) in patients with chronic glomerulonephritis (GN) and hypertension.

H Bras, H G Ochs, H Armbruster, R Heintz.   

Abstract

Patients with chronic glomerulonephritis and mild hypertension show a consistent behaviour in their renin-aldosterone-system. There is a close correlation between the elevation of mean blood pressure and destruction of glomeruli. No correlation has been found between renin values and the degree of hypertension. Thus the cuase of mild hypertension occurring in the early stages of chronic GN remains to be elucidated. Normal PRA values in spite of hypertension and expansion of ECFV accompaning progression of chronic glomerulonephritis could be a sign of "relative hyperreninemia". Apparently various mechanisms are involved in the pathogenesis of renal hypertension. These include sodium retention, increased cardiac output. anemia, renin, aldosterone, prostaglandins, expanded plasma volume and peripheral vasoconstriction. These factors are more or less active in the different stages of hypertension and renal failure.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 943254

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  3 in total

Review 1.  Glomerular function reserve and sodium sensitivity.

Authors:  Genjiro Kimura
Journal:  Clin Exp Nephrol       Date:  2005-06       Impact factor: 2.801

2.  Anti-inflammatory and renal protective actions of stanniocalcin-1 in a model of anti-glomerular basement membrane glomerulonephritis.

Authors:  Luping Huang; Gabriela Garcia; Yahuan Lou; Qin Zhou; Luan D Truong; Gabriel DiMattia; Xia Ru Lan; Hui Y Lan; Yanlin Wang; David Sheikh-Hamad
Journal:  Am J Pathol       Date:  2009-02-26       Impact factor: 4.307

Review 3.  Hypertension in children with chronic kidney disease: pathophysiology and management.

Authors:  Charlotte Hadtstein; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2007-11-08       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.